GGrantIndex
Sort

46,585 grants matching heart failure

Counterpulsation Device with Integrated EKG System for Chronic Partial Circulator

$908,941
Paul A Spence · Scr, Inc. · R44 · FY2013 · HL

Pre-Operative PSG Assessment of Cardiac Surgery Inpatients

$908,367
Hani Akram Kayyali · Cleveland Medical Devices, Inc. · R44 · FY2008 · NS

OCCLUDED ARTERY TRIAL--CLINICAL COORDINATING CENTER

$908,004
New York University School Of Medicine · U01 · FY2003 · HL

Cardiovascular Engineering Science

$907,663
Shu Chien · University Of California, San Diego · T32 · FY2009 · HL

Developing a MRI-guided Disease-Modifying Therapy for Post Infarction Chronic Heart Failure

$907,563
Rohan Dharmakumar · Cedars-Sinai Medical Center · R01 · FY2017 · HL

Ceramides as novel drivers of metabolic dysfunction and colorectal cancer

$907,536
Mary Christine Playdon · University Of Utah · U01 · FY2024 · CA

THE ATHEROSCLEROSIS RISK IN COMMUNITIES (ARIC) STUDY - FIELD CENTER - TASK ORDER 01, TASK AREA A

$907,148
Thomas Mosley · University Of Mississippi Med Ctr · N01 · FY2024 · HL

Improving Mitral Compensation in Ischemic Regurgitation

$905,680
Robert A Levine · Massachusetts General Hospital · R01 · FY2012 · HL

Study of Health Outcomes of Weight loss: Look AHEAD-Action for Health in Diabetes

$904,270
Steven E Kahn · Seattle Inst For Biomedical/Clinical Res · U01 · FY2010 · DK

Preclinical Development of a Novel Gene Therapeutic for Inclusion Body Myositis

$904,058
Buel Rodgers · Aavogen, Inc. · R44 · FY2022 · AG

Clinical Implications of Blood Pressure Patterns Among Older Adults

$903,833
Stephen P Juraschek · Beth Israel Deaconess Medical Center · R56 · FY2020 · HL

Integrated Cellular and Tissue Engineering for Ischemic Heart Disease

$903,257
Jianyi Zhang · University Of Alabama At Birmingham · U01 · FY2017 · HL

Exploration of novel block-and-lock agents alone and in combination for HIV remission in humanized mice

$903,157
Susana T Valente · University Of Florida · R01 · FY2023 · AI

The Look AHEAD Continuation: Action for Health in Diabetes

$903,114
Rena R Wing · Miriam Hospital · U01 · FY2010 · DK

Role of the giant protein titin in cardiac health and disease

$902,442
Henk L. Granzier · University Of Arizona · R35 · FY2024 · HL

Preventing Anthracycline Cardiovascular Toxicity with Statins

$900,665
William Gregory Hundley · Wake Forest University Health Sciences · R01 · FY2016 · HL

AI-driven Drug Discovery Targeting Cardiac Fibrosis in Aging Heart

$900,195
Joseph C Wu · Stanford University · UG3 · FY2025 · AG

Folic Acid for Vascular Outcome Reduction in Transplantation (FAVORIT) Trial

$900,000
Andrew G. Bostom · Rhode Island Hospital · U01 · FY2011 · DK

Genomics of blood pressure-induced target organ damage

$899,810
Aravinda Chakravarti · New York University School Of Medicine · R01 · FY2018 · HL

NHGRI/DIR Genomics Core

$898,791
Settara Chandrasekharappa · National Human Genome Research Institute · ZIC · FY2021 · HG

Transcatheter Device for Congestive Heart Failure Treatment Through Left Atrial Decompression

$898,558
Thomas Diffley Pate · Alleviant Medical, Inc. · R44 · FY2022 · HL

Prognostic Significance of microRNA Expression in Children with Cardiomyopathy

$898,361
Steven Edward Lipshultz · State University Of New York At Buffalo · R01 · FY2019 · HL

1/2 Allogeneic Human Mesenchymal Stem Cell (MSC) Injection in Patients with Hypoplastic Left Heart Syndrome: A Phase IIb Clinical Trial

$898,221
Stuart Berger · Lurie Children'S Hospital Of Chicago · UH3 · FY2023 · HL

Improving Self Care Behavior and Outcomes in Rural Patients with Heart Failure

$898,206
Kathleen A Dracup · University Of California, San Francisco · R01 · FY2007 · HL

Miniature MagLev VAD for Neonates and Pediatrics

$897,979
Barry N Gellman · Thoratec, Llc · R44 · FY2011 · HL